Biomedicines
https://www.researchpad.co/tools/openurl?pubtype=&doi=10.3390/biomedicines9070771&title=Poly (ADP-Ribose) Polymerase Inhibitor, ABT888, Improved Cisplatin Effect in Human Oral Cell Carcinoma&author=&keyword=[{keywordId=4, uniqueName=apoptosis, name=Apoptosis, contentId=301464}, {keywordId=40, uniqueName=oral-cancer, name=Oral cancer, contentId=301464}, {keywordId=303, uniqueName=cisplatin, name=cisplatin, contentId=301464}, {keywordId=363621, uniqueName=human-oral-cell-carcinoma, name=human oral cell carcinoma, contentId=301464}, {keywordId=363622, uniqueName=parp-inhibitors-(parpi), name=PARP inhibitors (PARPi), contentId=301464}, {keywordId=363623, uniqueName=veliparib-(abt888), last=true, name=veliparib (ABT888), contentId=301464}],[{keywordId=4, uniqueName=apoptosis, name=Apoptosis, contentId=301464}, {keywordId=40, uniqueName=oral-cancer, name=Oral cancer, contentId=301464}, {keywordId=303, uniqueName=cisplatin, name=cisplatin, contentId=301464}, {keywordId=363621, uniqueName=human-oral-cell-carcinoma, name=human oral cell carcinoma, contentId=301464}, {keywordId=363622, uniqueName=parp-inhibitors-(parpi), name=PARP inhibitors (PARPi), contentId=301464}, {keywordId=363623, uniqueName=veliparib-(abt888), last=true, name=veliparib (ABT888), contentId=301464}],[{keywordId=4, uniqueName=apoptosis, name=Apoptosis, contentId=301464}, {keywordId=40, uniqueName=oral-cancer, name=Oral cancer, contentId=301464}, {keywordId=303, uniqueName=cisplatin, name=cisplatin, contentId=301464}, {keywordId=363621, uniqueName=human-oral-cell-carcinoma, name=human oral cell carcinoma, contentId=301464}, {keywordId=363622, uniqueName=parp-inhibitors-(parpi), name=PARP inhibitors (PARPi), contentId=301464}, {keywordId=363623, uniqueName=veliparib-(abt888), last=true, name=veliparib (ABT888), contentId=301464}],[{keywordId=4, uniqueName=apoptosis, name=Apoptosis, contentId=301464}, {keywordId=40, uniqueName=oral-cancer, name=Oral cancer, contentId=301464}, {keywordId=303, uniqueName=cisplatin, name=cisplatin, contentId=301464}, {keywordId=363621, uniqueName=human-oral-cell-carcinoma, name=human oral cell carcinoma, contentId=301464}, {keywordId=363622, uniqueName=parp-inhibitors-(parpi), name=PARP inhibitors (PARPi), contentId=301464}, {keywordId=363623, uniqueName=veliparib-(abt888), last=true, name=veliparib (ABT888), contentId=301464}],[{keywordId=4, uniqueName=apoptosis, name=Apoptosis, contentId=301464}, {keywordId=40, uniqueName=oral-cancer, name=Oral cancer, contentId=301464}, {keywordId=303, uniqueName=cisplatin, name=cisplatin, contentId=301464}, {keywordId=363621, uniqueName=human-oral-cell-carcinoma, name=human oral cell carcinoma, contentId=301464}, {keywordId=363622, uniqueName=parp-inhibitors-(parpi), name=PARP inhibitors (PARPi), contentId=301464}, {keywordId=363623, uniqueName=veliparib-(abt888), last=true, name=veliparib (ABT888), contentId=301464}],[{keywordId=4, uniqueName=apoptosis, name=Apoptosis, contentId=301464}, {keywordId=40, uniqueName=oral-cancer, name=Oral cancer, contentId=301464}, {keywordId=303, uniqueName=cisplatin, name=cisplatin, contentId=301464}, {keywordId=363621, uniqueName=human-oral-cell-carcinoma, name=human oral cell carcinoma, contentId=301464}, {keywordId=363622, uniqueName=parp-inhibitors-(parpi), name=PARP inhibitors (PARPi), contentId=301464}, {keywordId=363623, uniqueName=veliparib-(abt888), last=true, name=veliparib (ABT888), contentId=301464}],&subject=